Fiche centre
Hôpital Necker-Enfants malades
Paris — France
Essais liés3clinical trials
VilleParislocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05001737
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Emapalumab | Lupus | Phase 3 | NCT05001737 | EMERALD — Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE | COMPLETED |
| delandistrogene moxeparvovec | Myopathies | Phase 2 | NCT06128564 | ENVOL — A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD) | ACTIVE_NOT_RECRUITING |
| EPIDEV-B6 — Evaluation by a Vineland II Scale of Long-term Development of Children With Pyridoxine Dependent Epilepsy | Épilepsie | À vérifier | NCT06054347 | EPIDEV-B6 — Evaluation by a Vineland II Scale of Long-term Development of Children With Pyridoxine Dependent Epilepsy | COMPLETED |